InvestorsHub Logo

nidan7500

08/12/17 7:53 PM

#115257 RE: Reyeton #115256

Rey, agree w/your thinking. Complex but possible link. If they do sign the message it sends about A2-73 is massive.

A_Good_Day_2

08/12/17 8:37 PM

#115258 RE: Reyeton #115256

How about this scenario:

The patent is rejected 3/28/17

AVXL receives great results from BIIB's MTA. Talks with BIIB bear fruit and a plan is hatched.

AVXL requests re-consideration of the patent with expanded use in MS in combination with BIIB's drug.

Patent is approved around Sept 1st.

AVXL/BIIB partnership is announced Sept 11th.

tradeherpete

08/12/17 11:47 PM

#115274 RE: Reyeton #115256

If the patent gives us the power to merge and license then that should get something going.

I’ve heard there are many options when merging. Others here are more knowledgable on that. Then there’s the FDA publication of the new rules. Could get interesting. Get ready for share price pandemonium. Ground Control to Major Tom.